ANVRX:NASDAQ
American Century Non-U.S. IntrinsicValue Fund R Class – ANVRX Fund Overview
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|
| 8.92 | 0.03 (+0.34%) | 7.82 - 10.26 | 0.0 |
Market data as of 12:00AM 04/02/25. Quotes are delayed by at least 15 min.
Overview - ANVRX
The investment seeks capital appreciation.
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of non-U.S. companies. It may invest in both developed and emerging markets and generally intends to invest across different countries and geographic regions. The fund may invest in common stock and other equity securities that are denominated in foreign currencies and may also invest in foreign securities that are represented in the U.S. securities markets by American Depositary Receipts (ADRs) or similar depositary arrangements.
Growth of $10,000 (10 Years)
| Total Return | 3.26% |
|---|
| Yield (Trailing 12 Mo.) | 2.22% |
|---|
| Expense Ratio | 1.69% |
|---|
| Front Load | None |
|---|
| Deferred Load | None |
|---|
| Minimum Investment | $2,500 |
|---|
| Management Tenure | 6 Years |
|---|
| Fund Inception | 12/03/2019 |
|---|
Trailing Total Returns - ANVRX
as of 02/28/2025
| Timeframe | ANVRX | S&P 500 | Foreign Large Value |
|---|
| 1 Month | 2.85% | -1.30% | 3.32% |
|---|
| 3 Month | 4.16% | -0.97% | 5.23% |
|---|
| Year-to-Date | 8.13% | 1.44% | 7.75% |
|---|
| 1 Year | 5.87% | 18.41% | 11.95% |
|---|
| 3 Year | 5.76% | 12.55% | 6.90% |
|---|
| 5 Year | 5.93% | 16.85% | 9.02% |
|---|
| 10 Year | -- | 12.98% | 4.77% |
|---|
| Since Inception | 3.26% | 11.12% | -- |
|---|
Sector Allocation - ANVRX
as of 02/28/2025
| Basic Materials | | 4.40% |
|---|
| Consumer Cyclical | | 23.00% |
|---|
| Financial Services | | 9.26% |
|---|
| Real Estate | | 0.00% |
|---|
| Consumer Defensive | | 11.66% |
|---|
| Healthcare | | 14.49% |
|---|
| Utilities | | 0.00% |
|---|
| Communication Services | | 9.99% |
|---|
| Energy | | 2.82% |
|---|
| Industrials | | 11.90% |
|---|
| Technology | | 12.47% |
|---|
Asset Allocation - ANVRX
as of 02/28/2025
| By Percent | Short | 0% | Long | Net |
|---|
| Stock | 0.00 | | | 4.61 | 4.61 |
|---|
| Bond | 0.00 | | | 2.02 | 2.02 |
|---|
| Other | 0.00 | | | 0.00 | 0.00 |
|---|
| Foreign Stock | 0.00 | | | 92.57 | 92.57 |
|---|
| Foreign Bond | 0.00 | | | 0.00 | 0.00 |
|---|
| Total | 0.00 | | | 99.20 | 99.20 |
|---|
| Cash | 0.00 | | | 0.81 | 0.81 |
|---|
| Total Net Assets | $568.35M |
|---|
| Total Stock Holdings | 52 |
|---|
| Total Bond Holdings | 1 |
|---|
Top Ten Holdings - ANVRX
as of 02/28/2025
| Company | YTD Return | % of Assets |
|---|
| British American Tobacco PLC | -- | 4.52% |
|---|
| Sanofi SA | -- | 4.33% |
|---|
| Samsung Electronics Co Ltd | -- | 4.17% |
|---|
| Roche Holding AG | -- | 4.15% |
|---|
| GSK PLC | -- | 4.07% |
|---|
| Reckitt Benckiser Group PLC | -- | 3.85% |
|---|
| SUMCO Corp | -- | 3.26% |
|---|
| Orange SA | -- | 3.09% |
|---|
| Teleperformance SE | -- | 2.91% |
|---|
| Verallia | -- | 2.90% |
|---|
Valuation & Growth - ANVRX
as of 02/28/2025
| Valuation | ANVRX | Category Range |
|---|
| Price/Earnings | 11.42 | |
|---|
| Price/Book | 1.04 | |
|---|
| Price/Sales | 0.65 | |
|---|
| Price/Cash Flow | 5.48 | |
|---|
| Dividend Yield | 5.96 | |
|---|
| LT Earnings | 9.26 | |
|---|
| Historical Earnings | 9.91 | |
|---|
| Sales Growth | 5.91 | |
|---|
| Cash-Flow Growth | 3.46 | |
|---|
| Book-Value Growth | 5.59 | |
|---|
